Publications by authors named "Wu Zufei"
We aimed to evaluate the correlation among serum parathyroid hormone (PTH) and slow-reflow during primary percutaneous coronary intervention (PCI) and prognosis in patients with ST-segment elevation myocardial infarction (STEMI). A total of 262 patients were enrolled and divided into a slow-reflow group (n = 61) and a control group (n = 201). PTH was an independent risk factor for slow-reflow (P < 0.
View Article and Find Full Text PDFArticle Synopsis
- The study focused on the relationship between serum parathyroid hormone (PTH) levels and in-hospital major adverse cardiovascular events (MACE) in patients who experienced acute ST-segment elevation myocardial infarction (STEMI) and underwent primary percutaneous coronary intervention (PCI).
- It included 340 patients, dividing them into a MACE group and a control group, using statistical tools like LASSO and logistic regression to identify risk factors and create a predictive model.
- Findings showed a positive correlation between PTH levels and the occurrence of MACE, with the developed nomogram model demonstrating strong predictive capability and better clinical benefits compared to existing models like the TIMI score.
Background: Vascular calcification (VC) is usually associated with cardiovascular diseases (CVDs), which are one of the main causes of mortality in the world. This study aimed to analyze the expression of circular RNAs (circRNAs) in patients with VC and to evaluate biomarkers for the diagnosis of VC.
Methods: Calcified human aortic endothelial cells (HAECs) and the calcification in mouse aorta were detected by qRT-PCR.